Rockville, MD, USA (PRWEB) September 23, 2013
Healthcare regulators, innovators, researchers, executives from pharmaceutical, biotechnology and medical device companies, and other regulatory professionals and stakeholders from around the world will gather at the Hynes Convention Center in Boston, 28 September–2 October, for 2013 RAPS: The Regulatory Convergence. The signature annual event of the Regulatory Affairs Professionals Society (RAPS), the Regulatory Convergence conference is largest annual gathering in world for the healthcare product regulatory profession.
The conference is expected to draw around 2,000 participants to hear about the latest developments in healthcare products, technology and regulation, and examine how regulations and regulatory systems are adapting to keep pace.
Among the regulators scheduled to speak are 27 officials from the US Food and Drug Administration (FDA), including Jeffrey E. Shuren, MD, JD, director of FDA’s Center for Devices and Radiological Health (CDRH) and Jay Crowley, senior advisor, patient safety, CDRH; Howard Sklamberg, director, Office of Compliance, Center for Drug Evaluation and Research; and Daniel Fabricant, PhD, director, Division of Dietary Supplement Programs, Office of Nutrition, Labeling and Dietary Supplements, CFSAN. In addition, representatives from agencies in Europe, China, Japan, Taiwan, India, Brazil, Canada, Indonesia and Malaysia will also speak.
“This is a very dynamic and exciting time in the pharmaceutical, medical technology and biotechnology industries, and for the regulatory professionals who help bring these innovative technologies to market as products,” said RAPS Executive Director Sherry K
Copyright©2012 Vocus, Inc.
All rights reserved